Govt should notify e-pharmacy rules as uncertainty dampens growth: Experts

The government should finalise and notify e-pharmacy rules immediately as the regulatory uncertainty dampens growth and new investment in the sector, according to the experts.

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Press Trust of India New Delhi
2 min read Last Updated : Oct 14 2020 | 8:47 PM IST

The government should finalise and notify e-pharmacy rules immediately as the regulatory uncertainty dampens growth and new investment in the sector, according to the experts.

Panellists on the discussion also said there remains ambiguity on the legality of marketplaces.

They were participating in a discussion on 'e-Pharmacy: Digitally Empowering Consumers & Small Businesses' organised by the Internet and Mobile Association of India (IAMAI).

"We must notify the rules which are catching dust within the ministry at the earliest opportunity... All e-pharmacies are governed by law and governed by the manner which is being spelt out in the law," Patients Safety and Access Founder Director Bejon Misra said.

The notification is pending and it should come out as soon as possible, he added.

"We must encourage healthy competition at the marketplace and we must encourage ethical players, we must recognise them," Misra said.

In a similar vein, 1mg Chief Operating Officer Tanmay Saksena said: "Our model is completely compliant under a combination of various regulations that already exist, what we are really requesting and hoping is that there will be harmonisation of all the regulations under one common aegis."

E-pharmacies are already operating under pre-defined regulations. We are subject to the Drugs and Cosmetics Act. We are purely platforms linking consumers to the pharmacies that already exist in the ecosystem and have introduced better trackability and traceability, he added.

The retail pharmacy sector needs a lot of supply chain, technology and access solutions to make healthcare delivery more efficient and affordable, and a prerequisite for this is a simple and clear regulatory pathway for innovation to thrive in this important space, IAMAI said in a statement.

It also expressed hope that the issues being faced by the e-Pharmacy sector will now be addressed through a quick notification of the pending e-Pharmacy draft rules, it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :E-Pharma

First Published: Oct 14 2020 | 8:37 PM IST

Next Story